[ad_1] (Bloomberg) — US regulators have approved the first blood test to help diagnose Alzheimer’s disease, potentially making it easier to find and treat patients with the mind-robbing disease that affects nearly 7 million Americans. The test made by Fujirebio Diagnostics Inc., a unit of Japan’s H.U. Group Holdings Inc., was cleared for people 55…
[ad_1] Sun Pharmaceutical Industries Ltd. has announced the acquisition of Nasdaq-listed Checkpoint Therapeutics, Inc., an immunotherapy and targeted oncology company, in a $355 million cash deal. The acquisition will bolster Sun Pharma’s onco-dermatology portfolio, adding Checkpoint’s recently FDA-approved cancer drug, UNLOXCYT (cosibelimab-ipdl), to its pipeline. The deal, expected to close in the second quarter of…
[ad_1] WASHINGTON (AP) — Federal officials on Thursday approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated with opioid medications like Vicodin and OxyContin. The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals’ pill, Journavx, for short-term pain that often follows surgery or injuries. It’s…
[ad_1] Few students go into medical research dreaming of one day giving a mouse a tumour or heart disease to a rabbit. But animal experimentation of this kind has become fundamental to modern medicine. For regulatory bodies around the world, treatments that might save human lives must be proven safe and effective in animals with…
